1. Local Tumor Flare Following Radiosurgery and Ipilimumab (Ipi) for Melanoma Brain Metastases: Increased Immune Response?. (15th February 2016) Authors: Chung, C.; Khoja, L.; Kurtz, G.; Bernstein, M.; Joshua, A.; Hogg, D.; Zadeh, G.; Laperriere, N.; Menard, C.; Millar, B.A.; Kongkham, P.; Butler, M. Journal: Radiotherapy and oncology Issue: Volume 118(2016)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparison of Arterial Input Functions by Magnitude and Phase Signal Measurement in DCE MRI of brain cancer patients. (15th February 2016) Authors: Coolens, C.; Foltz, W.; Driscoll, B.; Pellow, C.; Chung, C. Journal: Radiotherapy and oncology Issue: Volume 118(2016)Supplement 1 Page Start: S27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An Artificial Intelligence Platform for Asset Management Contributes to Better Decision‐making Tools for Operations, Maintenance, and Utility Management: Sen et al. (1st April 2018) Authors: Sen, D.; Fashokun, A.; Angelotti, R.; Brooks, M.; Bhaumik, H.; Card, C.; Lodhi, A.; Godrej, A.; Chung, C. Journal: Water environment research Issue: Volume 90:Number 4(2018) Page Start: 355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Butyrate via the gut-brain neural circuit reduces appetite and activates brown adipose tissue. (August 2018) Authors: Wang, Y.; Li, Z.; Yi, C.X.; Katiraei, S.; Kooijman, S.; Zhou, E.; Chung, C.; Gao, Y.; van den Heuvel, J.K.; Meijer, O.C.; Berbée, J.F.P.; Heijink, M.; Giera, M.; Willems van Dijk, J.A.P.; Groen, A.K.; Rensen, P.C.N. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase II trial of brentuximab vedotin (BV) and lenalidomide (Len) in relapsed and refractory (r/r) cutaneous (CTCL) and peripheral (PTCL) T-cell lymphomas. (2019) Authors: Maakaron, J.; Huang, Y.; Brammer, J.; Chung, C.; William, B. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A PHASE II TRIAL OF BRENTUXIMAB VEDOTIN (BV) AND LENALIDOMIDE (LEN) IN RELAPSED AND REFRACTORY (R/R) CUTANEOUS (CTCL) AND PERIPHERAL (PTCL) T‐CELL LYMPHOMAS: PRELIMINARY RESULTS OF A PHASE II TRIAL. (12th June 2019) Authors: William, B.M.; Abbasi, A.; Huang, Y.; Larbi, R.; Giali, R.; Yang, L.; Brammer, J.; Grantier, C.; Hoffman, C.; Ayyappan, S.; Baiocchi, R.; Epperla, N.; Christian, B.; Alinari, L.; Maddocks, K.; Chung, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0200 Relative effectiveness of rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis and an inadequate response to a single previous TNF inhibitor: Results from switch-RA, a global, comparative-effectiveness, observational study. (23rd January 2014) Authors: Emery, P.; Gottenberg, J.-E.; Sarzi-Puttini, P.; Moots, R.J.; Choquette, D.; Finckh, A.; Östör, A.; Andrianakos, A.; Barile-Fabris, L.; Desjuzeur, M.-L.; Hinsch-Gylvin, L.; Chung, C.; Mpofu, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0302 Results from the rate-ra study: a multicenter, open-label, single-arm study to evaluate the safety of administering rituximab at a more rapid infusion rate in patients with rheumatoid arthritis. (23rd January 2014) Authors: Pritchard, C. H.; Greenwald, M. W.; Kremer, J. M.; Gaylis, N. B.; Zlotnick, S.; Chung, C.; Jaber, B.; Reiss, W. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A879 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topical imiquimod monotherapy for indolent primary cutaneous B‐cell lymphomas: a single‐institution experience. (25th March 2020) Authors: Hwang, S.; Johnson, A.; Fabbro, S.; Hastings, J.; Haverkos, B.; Chung, C.; Porcu, P.; William, B. Journal: British journal of dermatology Issue: Volume 183:Number 2(2020) Page Start: 386 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0089 Utility of a Novel Inflammatory Marker, Glyca, for Assessment of Rheumatoid Arthritis Disease Activity and Coronary Atherosclerosis. (9th June 2015) Authors: Ormseth, M.; Chung, C.; Oeser, A.; Connelly, M.; Sokka, T.; Raggi, P.; Solus, J.; Otvos, J.; Stein, C.M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 452 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗